Visits climbed from about five a month to over 217 in a little more than a year. NSW Health warns that a polished label says nothing about what a vial contains.
Recap by typeshit. Post by New England Times on X.
MedPage Today
A JAMA Network Open analysis of Reddit posts also lists fatigue, insomnia and muscle symptoms. MedPage's roundup adds a CagriSema menopause analysis and Walmart's GLP-1 coverage plan.
A short teaser comparing how well people tolerate the two main GLP-1 ingredients, with the full breakdown behind the link.
Doctors quoted by Men's Journal raise concerns about how much GLP-1 users are paying for add-on supplements each month.
The anti-doping agency says many sellers use research chemical labels to dodge FDA scrutiny while selling peptides and SARMs.
Novo Nordisk shared the figure from a post-trial analysis of its next-generation experimental drug, with results broken out for women.
In a JAMA Network Open survey study of 3,615 adults, GLP-1 use was 20.5% with a cancer history versus 26.5% without, about 30% lower odds.
Loading…